Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials

ConclusionsOnset of clinical response for excessive daytime sleepiness and/or cataplexy was generally observed within the first 2 –3 weeks of pitolisant treatment in patients with narcolepsy.ClinicalTrials.gov identifierNCT01067222 (February 2010), NCT01800045 (February 2013).
Source: CNS Drugs - Category: Neurology Source Type: research